Phase II, Single-arm Study of AZD1775 Monotherapy in Relapsed Small Cell Lung Cancer Patients With MYC Family Amplification or CDKN2A Mutation Combined With TP53 Mutation
Clinical trial NCT02688907 · TERMINATED
Trial details
- NCT number
- NCT02688907
- Sponsor
- Samsung Medical Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-07
- Primary completion
- 2017-12-27
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.